TP53 and neoplasm: Wang et al. showed that stabilizing p53 in mutated tumor cell lines by small molecules, including, CP-31398, PRIMA1, and Nutlin, was accompanied by increased expression of TRAIL-R2, as well as a reduced tumor-burden in vivo models [56].